Saturday, October 31, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Oct 31, 2026·New filings added every weekday·Weekly prices as of Oct 2·What changed·
StockCIK 1827401

BRIGHT MINDS BIOSCIENCES INC. (DRUG): Insider Trades and Fund Holdings

In the past 12 months, BRIGHT MINDS BIOSCIENCES INC. insiders reported no open-market purchases and 1 sale worth $9.79M; 0 of the sales were reported as made under a 10b5-1 trading plan.

Loading drug price today from TradingView…

Price today, live from TradingView. Values and changes on this page use our weekly prices (as of Oct 2), so trades line up with filings. Why

0Insider buys, 12 months
$0Bought by insiders, 12 months
$9.79MSold by insiders, 12 months
1Tracked funds holding

DRUG price, with every reported trade

Hover or tap a marker to see who traded that week.

▲ insider buy▼ insider sale● Congress■ fund● planned sale■ 5% stake at prices of Oct 2

Prices and share counts are adjusted for the 1-for-6 reverse split around Jul 2023, so earlier figures are on today's share basis.

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Jun 30, 2026FundPoint72 Asset Management opened a position in Q2 2026 (13F filed Aug 14, 2026)
  2. Apr 28, 2026Insider saleOther insider Cormorant Asset Management, LP sold $9.8 million

Daily chart and analysis

Live daily prices and indicators from TradingView. The chart above uses our weekly prices so trades line up with filings.

Loading drug daily chart from TradingView…
Technical signals
Loading drug technical analysis from TradingView…
Company profile
Loading drug company profile from TradingView…

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Apr 30, 2026.

Recent DRUG insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Apr 30Apr 28Cormorant Asset Management, LPOther insiderOther insider (ind.)▼ SELL109,33189.50$9.79M−10%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 31, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Cormorant Asset Management, LPOther insider0$01$9.79MApr 30, 2026
0

Tracked funds that report DRUG

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Point72 Asset ManagementQ2 2026327,416$23.0M0.04%▲ New
Source: SEC Form 13F-HR filings, retrieved Oct 31, 2026. How we read filings

Related stocks

Other busy stocks in Health Care.

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →

Sources

  1. Form 4: Cormorant Asset Management, LP, sale · filed 2026-04-30
  2. 13F: Point72 Asset Management, Q2 2026

All 1 Form 4 filings for DRUG are in the table above, each linked to the SEC.

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.